Recent advancements in monoclonal antibody engineering are reshaping disease treatment, focusing on safety, effectiveness, and addressing current medical needs.

Avantor, Inc. (NYSE: AVTR) has announced an expanded partnership with the National Institute for Bioprocessing Research and ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia™ RidGS, a high-yield glutamine ...

R&D software developer Dotmatics is rolling out a platform for discovering and developing therapeutic antibodies and proteins ...

As per Future Market Insights (FMI) latest analysis, the global cell culture market is projected to total USD 44,593.1 million by 2034, up from USD 27,911.3 million in 2024. It will exhibit a CAGR of ...

The US Food and Drug Administration (FDA) has approved a new presentation of Alvotech and Teva Pharmaceuticals’ SELARSDI ...

Zoetis enjoys enviable financial flexibility, even as leverage ticked up in 2015 to finance the purchase of Pharmaq and Abbott's animal health business. With long-term debt at roughly $6.6 billion at ...

Can type 1 diabetes be managed or cured? Yes! Breakthrough treatments like Donislecel and Teplizumab offer hope for better ...

Japanese investments in North Carolina have totaled billions of dollars and created thousands of jobs in the state.

Dotmatics®, a leader in R&D scientific software connecting science, data, and decision-making, today announced the launch of ...